Publications by authors named "Kurtis D Davies"

Claim this Profile
I
Improved Methods for the Stable Generation of Human Papillomavirus-Driven Head and Neck Cancer Cell Lines.
Phuong N Le, Stephen B Keysar, Bettina Miller, J Jason Morton, Tugs-Saikhan Chimed, Kurtis D Davies

Mol Carcinog· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Concordance Study among 26 NGS Laboratories Participating in the NCI Molecular Analysis for Therapy Choice Clinical Trial.
Linda K Zane, Laura M Yee, Ting-Chia Chang, Jeffrey Sklar, Guangxiao Yang, Kurtis D Davies

Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finding Rearrangements in the Cell-Free DNA Haystack.
Kurtis D Davies

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular assessment of cystic sellar salivary gland-like lesions.
Joanne Lin, Timothy H Ung, Kurtis D Davies, Christie G Turin, Bette K Kleinschmidt-DeMasters

Clin Neuropathol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Double Fusion Underlying Crizotinib Resistance in a Metastatic Inflammatory Myofibroblastic Tumor: A Case Report.
Alessandra Maleddu, Trista K Hinz, Margaret A Black, Dara L Aisner, Carrie B Marshall, Kurtis D Davies

JTO Clin Res Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features and mutational frequency of renal cell carcinoma from patients undergoing kidney transplant evaluation.
Corbin J Eule, Junxiao Hu, Kurtis D Davies, Alkesh Jani, Thomas Pshak

Front Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun, Kurtis D Davies

Nature· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Radiographic Benefit of a Patient With Metastatic Non-Small Cell Lung Cancer Harboring an Fusion Through Use of EGFR Tyrosine Kinase Inhibitors.
Amy Guimaraes-Young, Kurtis D Davies, Patricia Trevisan, Hala Nijmeh, Mary Haag

JCO Precis Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun, Kurtis D Davies

Nature· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Clinical Prognostication of Endometrial Carcinomas Based on Next-Generation Sequencing and Immunohistochemistry-Real-World Implementation and Results at a Tertiary Care Center.
Kurtis D Davies, Lynelle P Smith, Amy Guimaraes-Young, Bradley R Corr, Christine M Fisher

Int J Gynecol Pathol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
L2086F Mutant ROS1-Rearranged NSCLC Resistant to Repotrectinib Responds to Cabozantinib: A Case Report.
Urs Weber, Kurtis D Davies, D Ross Camidge

JTO Clin Res Rep· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MIG6 Mediates Adaptive and Acquired Resistance to ALK/ROS1 Fusion Kinase Inhibition through EGFR Bypass Signaling.
Nan Chen, Logan C Tyler, Anh T Le, Eric A Welsh, Bin Fang, Kurtis D Davies

Mol Cancer Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational Signatures in Cancer: Laboratory Considerations and Emerging Applications.
Fei Dong, Kurtis D Davies

J Mol Diagn· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of acquired resistance in a ROS1 KRAS G12C NSCLC through the MAPK pathway.
Katherine Priest, Anh Le, Amanuail Gebregzabheir, Hala Nijmeh, Gregory B Reis, Kurtis D Davies

NPJ Precis Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERBB2 (HER2) Alterations in Colorectal Cancer.
Sinchita Roy-Chowdhuri, Kurtis D Davies, Lauren L Ritterhouse, Anthony N Snow

J Mol Diagn· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MET Exon 14 Skipping Mutations: Essential Considerations for Current Management of Non-Small-Cell Lung Cancer.
Kurtis D Davies, Lauren L Ritterhouse, Anthony N Snow, Nikoletta Sidiropoulos

J Mol Diagn· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Exon 14 Skipping Mutations in Non-Small-Cell Lung Cancer: An Overview of Biology, Clinical Outcomes, and Testing Considerations.
Mark A Socinski, Nathan A Pennell, Kurtis D Davies

JCO Precis Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Pathology Education: An Association for Molecular Pathology Webinar Series on Emerging and Evolving Biomarkers Structured for Specific Audiences.
Lucia P Barker, Lauren L Ritterhouse, Anthony N Snow, Kurtis D Davies

J Mol Diagn· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can adult -wildtype glioblastomas with fusions be reliably predicted by histological features?
Ahmed Gilani, Kurtis D Davies, Bette K Kleinschmidt-DeMasters

Clin Neuropathol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel RAF Fusions in Pediatric Low-Grade Gliomas Demonstrate MAPK Pathway Activation.
Katherine T Lind, Hannah V Chatwin, John DeSisto, Philip Coleman, Bridget Sanford, Kurtis D Davies

J Neuropathol Exp Neurol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular features of subungual melanomas are site-specific and distinct from acral melanomas.
Blair N Holman, Robert J Van Gulick, Carol M Amato, Morgan L MacBeth, Kurtis D Davies

Melanoma Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular characterization of a multi-institutional cohort of pediatric spinal cord low-grade gliomas.
Sydney T Grob, Liana Nobre, Kristen R Campbell, Kurtis D Davies, Scott Ryall

Neurooncol Adv· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma.
Anandani Nellan, Erin Wright, Kristen Campbell, Kurtis D Davies, Andrew M Donson

J Neurooncol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Tissue Molecular Biomarker Testing Turnaround Times and Concordance Between Standard of Care and the Biocartis Idylla Platform in Patients With Colorectal Cancer.
Gregory J Tsongalis, M Rabie Al Turkmani, Michael Suriawinata, Michael J Babcock, Kristi Mitchell, Kurtis D Davies

Am J Clin Pathol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targetable molecular alterations in congenital glioblastoma.
Ahmed Gilani, Andrew Donson, Kurtis D Davies, Susan L Whiteway, Jessica Lake

J Neurooncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis